beta integrin antagonists (Lund Research Center)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namebeta integrin antagonists (Lund Research Center)
Drug Alias Nameanti-inflammatories (Lund Research Center)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin antagonists
TargetsIntegrin
Therapy Area/IndicationsAsthmaArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesActive Biotech Research AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesActive Biotech Research AB
Active IndicationsN/A
Inactive IndicationsAsthmaArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A